
Antisense Oligonucleotide in vitro screening assays: 5 key considerations to make better predictions

Moving Beyond the 'One Disease, One Drug' Paradigm to Navigate Neurodegenerative Disease Complexity
.png)
Expert Insights: Innovative Discovery Strategies for Proteinopathies

Expert Insights: how to mitigate risk and be successful in neurodegenerative drug discovery

Research highlights: Targeted Protein Degradation in Tauopathies

Case Study: Development of a human iPSC-derived ALS model